Çocuk Yoğun Bakım Ünitesinde Yatan Kritik Hastalığı Olan Çocuklarda D Vitamini Düzeyi ile Klinik İzlem Arasında İlişki Var mı?

Yıl 2024, Cilt: 57 Sayı: 3, 105 - 109, 22.01.2025

Tuğçe Güzelkaş , Handan Alp

https://doi.org/10.20492/aeahtd.1447582

Öz

Giriş: D vitamini enfeksiyonlar, otoimmün sistem, kardiyovasküler sistem ve merkezi sinir sistemi üzerine etki gösteren bir hormondur; bu nedenle kritik hastalar için önemli olduğu düşünülmektedir. Bu çalışmada, kritik hastalığı olan çocuklardaki D vitamini düzeyi ile Pediatrik Mortalite Riski (PRISM)III skoru ve mortalite oranları arasındaki ilişkinin incelenmesi amaçlanmıştır.
Gereç ve Yöntem: Bu çalışmaya Atatürk Üniversitesi Çocuk Yoğun Bakım Ünitesine Ocak 2016 ile Ocak 2017 tarihleri arasında yatırılan toplamda 200 hasta dahil edildi. Demografik veriler, PRISM III skoru, serum kalsiyum (Ca), fosfor (P), alkalen fosfataz (ALP), parathormon (PTH) ve 25-Hidroksi-Vitamin-D [25(OH)D] seviyeleri kaydedildi. 25(OH)D seviyeleri eksiklik (12 ng/ml altı), yetersizlik (12-20 ng/ml), yeterlilik (20-100 ng/ml) ve fazlalık olarak gruplandırıldı (100 ng/ml üzeri).
Bulgular: Hastaların %23,5'inin D vitamini düzeyi eksik, %24,5’inin yetersiz, %52’sinin yeterliydi. D vitamini ile yaş arasında negatif korelasyon saptandı (r=-0,42, p<0,010). D vitamini yeterli olan hastalarda PRISM III skoru daha düşük bulundu (p<0,010). D vitamini eksikliği olan hastaların ölüm oranı daha yüksek olmakla beraber anlamlı bulunmadı. D vitamini düzeyi ile hastanede yatış süresi, mekanik ventilatör süresi, kronik hastalık durumu ya da vazopressör ihtiyacı arasında anlamlı ilişki saptanmadı.
Sonuçlar: PRISM skorlama sistemi mortaliteyi öngörme açısından çocuk yoğun bakım ünitelerinde sıklıkla kullanılan bir skorlama sistemidir. D vitamini seviyesi yetersiz veya eksik olan hastalarda PRISM III skorunun daha yüksek olması, D vitamini yetersizliği veya eksikliğinin mortalite için bir risk faktörü olduğunu düşündürebilir.

Anahtar Kelimeler

D vitamini, Mortalite, PRISM III, Kritik hasta çocuk

Is There Any Relationship between Clinical Progress and Vitamin-D Levels in Critically Ill Children?

Öz

Introduction: Vitamin-D is a hormone that affects infections, the autoimmune system, the cardiovascular system, and the central nervous system; therefore, it is considered important for critically ill patients. This study aimed to examine the relationship between vitamin-D levels and Paediatric Risk of Mortality (PRISM)III score and mortality rates in critically ill children.
Method: A total of 200 patients who were admitted to Atatürk University Paediatric Intensive Care Unit between January 2016 to January 2017 were included in this study. Demographic data, PRISM III score, serum calcium, phosphorus, alkaline phosphatase, parathormone, and 25-Hydroxy-Vitamin-D [25(OH)D] levels were recorded. 25(OH)D levels were grouped as deficiency (below 12 ng/ml), insufficiency (12-20 ng/ml), sufficiency (20-100 ng/ml), and excess (above 100 ng/ml).
Results: Vitamin-D levels of 23.5% of the patients were deficient, 24.5% were insufficient, and 52% were sufficient. A negative correlation was found between vitamin-D and age (r=-0.42, p<0.01). PRISM III score was found to be lower in patients with sufficient vitamin-D (p<0.01). Although the mortality rate of cases with vitamin-D deficiency was higher, it was not found to be significant. No significant relationship was found between vitamin-D level and duration of hospitalization, duration of mechanical ventilation, chronic disease status, or vasopressor need.
Conclusion: PRISM scoring system is a scoring system frequently used in paediatric intensive care units to predict mortality. The higher PRISM III score in patients with insufficient or deficient vitamin-D levels may suggest that vitamin-D insufficiency or deficiency is a risk factor for mortality.

Anahtar Kelimeler

vitamin D, mortality, PRISM III, critical ill children

Teşekkür

We thank Assoc. Prof. Pelin Çelik, for her invaluable comments on the manuscript.

Kaynakça

• 1. Rosen CJ, Adams JS, Bikle DD, Black MD, Demay MD, Manson JE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocrine reviews 2012; 33(3): 456-92.
• 2. Toniato E, Spinas E, Saggini A, Kritas SK, Caraffa A, Antinolfi P, et al. Immunomodulatory effects of vitamin D on skin inflammation. J Biol Regul Homeost Agents 2015; 29(3): 563-7.
• 3. Wessels I, Rink L. Micronutrients in autoimmune diseases: possible therapeutic benefits of zinc and vitamin D. The Journal of nutritional biochemistry 2020; 77: 108240.
• 4. Lai Y-H, Fang T-C. The pleiotropic effect of vitamin D. International Scholarly Research Notices 2013; 2013.
• 5. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiological reviews 2016; 96(1): 365-408.
• 6. Notz Q, Herrmann J, Schlesinger T, Kranke P, Sitter M, Philipp H, et al. Vitamin D deficiency in critically ill COVID-19 ARDS patients. Clinical Nutrition 2022; 41(12): 3089-95.
• 7. Lasky-Su J, Dahlin A, Litonjua AA, Roger AJ, McGeachie MJ, Baron RM, et al. Metabolome alterations in severe critical illness and vitamin D status. Critical Care 2017; 21: 1-10.
• 8. Asilioglu N, Cigdem H, Paksu MS. Serum vitamin D status and outcome in critically ill children. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine 2017; 21(10): 660.
• 9. Atalan HK, Gucyetmez B. Serum vitamin D level at ICU admission and mortality. Turkish journal of anaesthesiology and reanimation 2017; 45(4): 193.
• 10. Aygencel G, Turkoglu M, Tuncel AF, Candir BA, Bildaci YD, Pasaoglu H. Is vitamin D insufficiency associated with mortality of critically ill patients? Critical care research and practice 2013; 2013.
• 11. Turkoglu M, Aygencel G, Dizbay M, Tuncel AF, Candir BA, Bildaci YD, et al. Is vitamin D deficiency associated with development of Acinetobacter baumannii infections in critically ill patients? Journal of Critical Care 2013; 28(5): 735-40.
• 12. Bhadoria P, Bhagwat AG. Severity scoring systems in paediatric intensive care units. Indian J Anaesth 2008; 52(suppl 5): 663- 75.
• 13. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Critical care medicine 1996; 24(5): 743-52.
• 14. Munns FC, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. Global consensus recommendations on prevention and management of nutritional rickets. Hormone research in paediatrics 2016; 85(2): 83-106.
• 15. Stanley LF. Reference intervals for laboratory tests and procedures. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF (eds) Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier. 2015: 3465-72.
• 16. Madden K, Feldman HA, Smith EM, Gordon CM, Keisling SM, Sullivan RM, Hollis BW, et al. Vitamin D deficiency in critically ill children. Pediatrics 2012; 130(3): 421-8.
• 17. Rey C, Sánchez-Arango D, López-Herce J, Martínez-Camblor P, García-Hernández I, Prieto B, et al. Vitamin D deficiency at pediatric intensive care admission. Jornal de pediatria 2014; 90: 135-42.
• 18. Hebbar KB, Wittkamp M, Alvarez JA, McCracken CE, Tangpricha V. Vitamin D deficiency in pediatric critical illness. Journal of clinical & translational endocrinology 2014; 1(4): 170-5.
• 19. Korwutthikulrangsri M, Mahachoklertwattana P, Lertbunrian R, Chailurkit L-O, Poomthavorn P. Vitamin D deficiency and adrenal function in critically ill children. J Med Assoc Thai 2015; 98(4): 365-72.
• 20. Ponnarmeni S, Kumar Angurana S, Singhi S, Bansal A, Dayal D, Kaur R. Vitamin D deficiency in critically ill children with sepsis. Paediatrics and international child health 2016; 36(1): 15-21.
• 21. Prasad S, Raj D, Warsi S, Chowdhary S. Vitamin D deficiency and critical illness. The Indian Journal of Pediatrics 2015; 82: 991- 5.
• 22. McNally JD, Menon K, Chakraborty P, Fisher L, Williams KA, Al-Dirbashi OY, et al. The association of vitamin D status with pediatric critical illness. Pediatrics 2012; 130(3): 429-36.
• 23. Khanna R, Nandy D, Senapati S. Systematic review and meta-analysis to establish the association of common genetic variations in Vitamin D binding protein with chronic obstructive pulmonary disease. Frontiers in genetics 2019; 10: 413.
• 24. Hatun S, Bereket A, Ozkan B, Coskun T, Kose R, Calıkoglu AS. Free vitamin D supplementation for every infant in Turkey. Archives of disease in childhood 2007; 92(4): 373-4.
• 25. Ogus E, Surer H, Kılınc A, Fidanci V, Yilmaz G, Dindar N, et al. D Vitamini düzeylerinin aylara, cinsiyete ve yaşa göre değerlendirilmesi. Ankara Medical Journal 2015; 15(1).
• 26. Lucidarme O, Messai E, Mazzoni T, Arcade M, Du Cheyron D. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive care medicine 2010; 36(9): 1609-11.
• 27. Palomer X, González Clemente J, Blanco Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2008; 10(3): 185-97.
• 28. González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24(5): 503-10.
• 29. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Digestive diseases and sciences 2010; 55: 2624-8.
• 30. Tekerek NU, Akyildiz BN. üçüncü basamak bir merkezde çocuk yoğun bakım hastalarının prognozunun değerlendirilmesi. Türkiye Çocuk Hastalıkları Dergisi 2017; 11(4): 221-5.
• 31. Oz O, Bayraktar S, Elevli M, Duru HNS, Civilibal M, Sahin K. Bir Egitim ve Araştırma Hastanesi Çocuk Yoğun Bakım Ünitesine Yatan Hastaların Değerlendirilmesi. Çocuk Acil ve Yoğun Bakım Dergisi 2015, 2: 65-70.
• 32. Conviser JH, Fisher SD, McColley SA. Are children with chronic illnesses requiring dietary therapy at risk for disordered eating or eating disorders? A systematic review. International Journal of Eating Disorders 2018; 51(3): 187-213.
• 33. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. The American journal of clinical nutrition 2004; 80(6): 1678S-88S.
• 34. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circulation: Cardiovascular Quality and Outcomes 2012; 5(6): 819-29.
• 35. Bekir U, Delibasi T. Vitamin D ve Kardiyovasküler Hastalık. Abant Tıp Dergisi 2015; 4(4): 428-35.
• 36. de Haan K, Groeneveld A, de Geus HR, Egal M, Struijs A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Critical care 2014; 18(6): 1-8.
• 37. McNally JD, Nama N, O’Hearn K, Sampson M, Amrein K, Iliriani K, et al. Vitamin D deficiency in critically ill children: a systematic review and meta-analysis. Critical Care 2017; 21(1): 1-13.
• 38. Su G, Jia D. Vitamin D in acute and critically sick children with a subgroup of sepsis and mortality: a meta-analysis. Nutrition and Cancer 2021; 73(7): 1118-25.
• 39. Sankar J, Lotha W, Ismail J, Anubhuti C, Meena RS, Sankar MJ. Vitamin D deficiency and length of pediatric intensive care unit stay: a prospective observational study. Annals of intensive care 2016; 6(1): 1-9.
• 40. Rippel C, South M, Butt WW, Shekerdemian LS. Vitamin D status in critically ill children. Intensive care medicine 2012; 38: 2055-62.